Autopsy report · NCT02545127

Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely

“The trial was prematurely terminated. Termination was not because of safety concerns but due to slow recruitment.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 years 9 months before it started.
• Ran for about 1 year 5 months before it stopped.
• 4 participants enrolled.
• Results were posted on the registry 1 year 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Ferring Pharmaceuticals

Sponsor type

Industry

Conditions

Preterm Delivery; Inadequate Milk Production

Interventions

Merotocin; Placebo

Participants

4

Sites

10

Countries

United States

Trials that died the same way

• Effects of Upper Extremity Rehabilitation Using Smart Glove in Stroke Patients
  “The trial was prematurely terminated due to slow recruitment.” (91% match in meaning)
• Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab
  “The recruitment was terminated early due to delays and slow recruitment that significantly jeopardized the trial timelines. There were no safety concerns related to the early termination of the trial.” (88% match in meaning)
• A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19
  “The trial prematurely terminated due to the inability to recruit the planned number of subjects. The decision to terminate the trial was not based on any safety concerns.” (87% match in meaning)
• Study of the Combination of Binimetinib and Encorafenib in Adolescent Patients With Unresectable or Metastatic BRAF V600-mutant Melanoma
  “The trial was terminated early on 05 October 2022 due to non-feasibility and poor recruitment and not based on safety concerns.” (82% match in meaning)
• A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer
  “The trial was terminated for strategic reasons. The decision was not based on any safety and/or efficacy concerns.” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.